Stock Alert: Ligand, (LGND) Trades 9.11% Higher June 23

Equities Staff  |

Ligand Pharmaceuticals, Inc. - Class B (NASDAQ:LGND) stock was among today's market movers, concluding trading up 9.11% to $87.81 on June 23.

172,602 shares exchanged hands compared to the 30-day daily average of 164,291 shares.

The company's stock has climbed 47.90% so far in 2022.

Ligand, shares have fluctuated between $72.57 and $169.98 over the past twelve months.

The company expects its next earnings on 2022-07-28.

For technical charts, analysis, and more on Ligand, visit the company profile.

About Ligand Pharmaceuticals, Inc. - Class B

Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenx Inc., the company went public in 1992.

To get more information on Ligand Pharmaceuticals, Inc. - Class B and to follow the company's latest updates, you can visit the company's profile page here: Ligand Pharmaceuticals, Inc. - Class B's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content